Remifentanil Intravenous Patient Controlled Analgesia (IVPCA) for Ablation of Idiopathic Ventricular Tachycardia
Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
Determine effects of remifentanil conscious sedation in patients undergoing
Electrophysiological (EP) studies for the ablation of idiopathic ventricular tachycardia
and/or persistent frequent premature ventricular contractions (PVCs) of non-ischemic origin
Phase:
Phase 4
Details
Lead Sponsor:
New York University School of Medicine NYU Langone Health